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Abstract: Today, there is increasing interest in discovering new bioactive compounds derived from
ethnomedicine. Preparations of guava (Psidium guajava L.) leaves have traditionally been used to
manage several diseases. The pharmacological research in vitro as well as in vivo has been widely
used to demonstrate the potential of the extracts from the leaves for the co-treatment of different
ailments with high prevalence worldwide, upholding the traditional medicine in cases such as
diabetes mellitus, cardiovascular diseases, cancer, and parasitic infections. Moreover, the biological
activity has been attributed to the bioactive composition of the leaves, to some specific phytochemical
subclasses, or even to individual compounds. Phenolic compounds in guava leaves have been
credited with regulating blood-glucose levels. Thus, the aim of the present review was to compile
results from in vitro and in vivo studies carried out with guava leaves over the last decade, relating
the effects to their clinical applications in order to focus further research for finding individual
bioactive compounds. Some food applications (guava tea and supplementary feed for aquaculture)
and some clinical, in vitro, and in vivo outcomes are also included.
Keywords: Psidium guajava L. (guava) leaves; traditional medicine; in vitro; in vivo; phenolic
compounds; pharmacology
1. Introduction
Ethnomedicine, which refers to the study of traditional medical practice, is an integral part of
the culture and the interpretation of health by indigenous populations in many parts of the world [1].
For example, Indian Ayurveda and traditional Chinese medicine are among the most enduring folk
medicines still practiced. These systems try to promote health and improve the quality of life, with
therapies based on the use of indigenous drugs of natural origin [2]. Given that plants have been
widely used as herbal medicines, several approaches are now being carried out to discover new
bioactive compounds [3].
Psidium guajava L., popularly known as guava, is a small tree belonging to the myrtle family
(Myrtaceae) [4]. Native to tropical areas from southern Mexico to northern South America, guava trees
have been grown by many other countries having tropical and subtropical climates, thus allowing
production around the world [5]. Traditionally, preparations of the leaves have been used in folk
medicine in several countries, mainly as anti-diarrheal remedy [6]. Moreover, other several uses have
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been described elsewhere on all continents, with the exception of Europe [6–8]. Figure 1 summarizes the
main traditional uses of guava leaves in the main producer countries. Depending upon the illness, the
application of the remedy is either oral or topical. The consumption of decoction, infusion, and boiled
preparations is the most common way to overcome several disorders, such as rheumatism, diarrhea,
diabetes mellitus, and cough, in India, China, Pakistan, and Bangladesh [6–9], while in Southeast Asia
the decoction is used as gargle for mouth ulcers [6,8,9] and as anti-bactericidal in Nigeria [8,9]. For skin
and wound applications, poultice is externally used in Mexico, Brazil, Philippines, and Nigeria [6–9].
In addition, chewing stick is used for oral care in Nigeria [9].
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phenolic compounds have been claimed to be food for specified health use (FOSHU), since they have
beneficial health effects related to the modulation of blood–sugar level [12]. Thus, the aim of this
review was to summarize the biological activities, in vitro and in vivo, studied in the last decade on
P. guajava L. leaves, relating them to the international classification of diseases provided by the World
Health Organization. In addition, the beneficial effects of some applications of guava leaves are also
been examined. For this purpose, a comprehensive review of the literature from 2004 to 2016 was done,
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“in vitro”, “in vivo”, “clinical”, “trial”, “food applicatio ”, and those related wi h the dis ases such
as “bacteria”, “cancer”, “blood”, “glycaemia”, and “oral”, among others were matched in the search.
Only complete available works published in English, Spanish, and Portuguese have been included.
Int. J. Mol. Sci. 2017, 18, 897 3 of 31
2. Pharmacological Properties
2.1. In Vitro Studies
2.1.1. Infectious and Parasitic Diseases
Aqueous and organic extracts of guava leaves have been demonstrated to have antibacterial
activity due to an inhibitory effect against antibiotics-resistant clinical isolates of Staphylococcus
aureus strains [13,14]. Despite using the same diffusion method, differences are noticed in their
inhibition zones, as shown in Table 1, probably due to extraction method or the dose assayed.
A methanol extract exerted antibacterial effects, preventing the growth of different strains from
several bacteria such as Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus spp.,
and Shigella spp. [15]. Furthermore, different extracts of the leaves such as aqueous, acetone–water,
methanolic, spray-dried extracts, and the essential oil, showed potential inhibitory activity against
Gram-positive and Gram-negative bacteria and fungi [16–20]. In these works, it is noticeable that
Gram-positive bacteria exhibited greater inhibition zones and minimum inhibitory concentrations
(MICs) than Gram-negative. Concerning the anti-fungal activity, less inhibition than bacteria is
reported [16,17], except for Candida krusei and Candida glabrata which provided higher inhibition [18],
and for Aspergillus spp. for which no activity was found [16] (Table 1). Moreover, Bezerra et al. [21]
evaluated the effect of guava leaves on different bacterial strains, concluding that the synergistic action
between the leaves and various antibiotics boosted its anti-bacterial activity. This effect was also
observed by Betoni et al. [22] with target drugs for the protein synthesis, cell-wall synthesis, and folic
acid. However, the latter did not find synergic effect with gentamicin, perhaps because the time of
maceration was lower than the time used by Bezerra et al. [21], and also the solvent was different
(Table 1).
Metwally et al. [23] associated the antimicrobial activity against some bacteria and fungi with
five flavonoids isolated from the leaves. This effect was also related to the concentration of tannins
in the leaves [24] and to the content of gallic acid and catechin [19]. Additionally, the activity against
bacterial and fungal pathogens was traced to betulinic acid and lupeol [25]. In fact, these works are
focused on the activity of these compounds, rather than on the effect of the whole extract of the leaves.
In addition, leaf acetone extract of P. guajava has also exhibited moderate acaricidal and insecticidal
activities causing the dead of Hippobosca maculata adult fly [26].
Furthermore, Adeyemi et al. [27] suggested that an ethanol extract from the leaves function as
a trypanocide agent, since its inhibition of Trypanosoma brucei brucei growth proved similar to that
of the reference drugs. Kaushik et al. [28] proposed the leaves as an anti-malaria agent, due to their
inhibitory activity and the resistance indices. Furthermore, the effect of guava leaf essential oil against
toxoplasmosis caused by the growth of Toxoplasma gondii were reported [29]. Additionally, guava leaves
were proposed for the treatment of diarrhea caused by enteric pathogens, since it showed significant
inhibitory activity against Vibrio cholerae and V. parahemolyticus, Aeromonas hydrophila, Escherichia coli,
Shigella spp. and Salmonella spp. [30–32]. It is suppose that the same plant origin and similar extraction
procedure makes that these works show comparable inhibition zones for the bacteria tested [30,31], in
contrast to the leaves of India and Bangladesh, where MIC values did not show any concordance [31,32]
(Table 1). In addition, a reduction was described for S. flexneri and V. cholera invasion and for their
adherence to the human laryngeal epithelial cells, and for the production of E. coli heat labile toxin
and cholera toxin, as well as their binding to ganglioside monosialic acid enzyme [33]. Moreover,
other studies also demonstrated the antimicrobial effect of some bacteria that cause gastrointestinal
disorders by different methods [34,35]. In contrast to previous results [20,31], no inhibition of the
hydrodistillation and n-hexane extract was found against E. coli Salmonella spp. [31] (Table 1).
Furthermore, guava leaf tea helped control of the growth of influenza viruses, including
oseltamivir-resistant strains, via the prevention of viral entry into host cells, probably due to the
presence of flavonols [36].
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Table 1. In vitro assays against infectious and parasitic diseases.
Origin Extraction Method Major Constituent Microorganisms Assay Main Results Ref.
Saudi Arabia Decoction (30 min) - Staphylococcus aureus strains Agar well diffusion assay At 200 µL: iz ≤ 30 mm. [13]
India Soxhlet with MeOH (12 h),maceration in H2O (4 h)
- S. aureus strains
Agar well diffusion assay,
time-kill of bacterial cell,
SDS-PAGE analysis, and
cellular toxicity to human
erythrocytes assays
At 20 mg/L: iz ≤ 20 mm, MIC: 25 µg/mL
(MeOH) and 7.5 mg/mL (H2O). MBC: 1.25 and
12.5 mg/mL, respectively, 10 h to kill bacteria,
↑ degradation of protein, no hemolysis.
[14]
Nigeria Maceration in MeOH (48 h) -
S. aureus, Escherichia coli,
Pseudomonas aeruginosa,
Proteus spp., and Shigella spp.
Agar well diffusion assay At 20 mg/mL: iz ≤ 18 mm; 81.8%prevention growth. [15]
India Maceration with agitation inMeOH, Ac, and DMF (12 h) -
G-p and G-n bacteria and fungi
(91 clinically important strains) Disc diffusion assay
At 25 mg/mL: against g-p 70% MeOH > 80%
Ac > 50% DE, ↓ 76.36% g-n bacteria. Fungi 56%
Ac > 38% ME > 31% DMF. No activity against
Citrobacter spp., Alcaligenes fecalis, and
Aspergillus spp.
[16]




Bacteria (Bacillus subtilis, S. aureus
and E. coli), and fungi
(Candida albicans and
Aspergillus niger)
Paper disc diffusion assay
At 50 µg/mL: iz ≤ 12.6 mm and 10 mm for
bacterial and fungi strains, respectively. E. coli:




Maceration with stirring in
EtOH:H2O 70% (v/v) (50 ◦C,
1 h)
TPC: 25.93 (% m/m, dry base),
TFC: 23.48 (mg/g, dry base)
Fungi (C. albicans, Candida krusei,
and Candida glabrata), G-p
(S. aureus) and G-n (E. coli and
P. aeruginosa)
Microdilution assay
MIC = 80–100 µg/mL (C. krusei, C. glabrata and





or Ac:H2O 70% (v/v)
(20 min)
Gallic acid: 0.065 µg/g,
Catechin: 1.04 µg/g
G-p strains (S. aureus,
Staphylococcus epidermidis, and
Enterococcus faecalis) G-n (E. coli,
Salmonella enteritidis, Shigella
flexneri, and Klebsiella pneumoniae)
Agar-diffusion and
microdilution assays
At 5 mg/mL: iz ≤ 20 mm, MIC = 39 µg/mL
(S. epidermis), MIC < 600 µg/mL (the others). [19]





G-p: S. aureus, Streptoccocus
faecalis, Bacillus subtillis,
Lactobacillus spp., Enterococcus
aerogenes, Acinetobacter spp. G-n:
E. coli, Proteus vulgari, Enterobacter
aerogenes, Salmonella typhimurium,
P. aeruginosa, and K. pneumoniae
Agar well diffusion assay At 80 µL: iz ≤ 27 mm, MIC = 3–10 µL. [20]
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Table 1. Cont.
Origin Extraction Method Major Constituent Microorganisms Assay Main Results Ref.
Brazil Maceration in EtOH:H2O70% (v/v) (72 h) - E. coli, P. aeruginosa, and S. Aureus Microdilution assay
Only S. aureus (MIC = 256 mg/mL). Synergic
effect with ciprofloxacin and gentamicin at
1024 mg/mL.
[21]
Brazil Maceration in MeOH:H2O70% (v/v) (48h) - S. aureus strains Disc diffusion assay
MIC 90% = 0.52 mg/mL, at 131.75 mg/mL
synergic effect with tetracycline,
chloramphenicol, erythromycin, vancomycin,
oxacillin, cephalothin, ampicillin, cefoxitin,
cotrimoxazole.
[22]




S. aureus, E. coli, P. aeruginosa, and
C. albicans Agar well diffusion assay
S. aureus: ↑ iz quercetin (28 mm), MIC (µg/mL)
guajaverin (0.09–0.19) < avicularin (0.09–0.38) <
quercetin (1.25) for all the microorganism tested.
[23]
Indonesia Maceration in EtOH:H2O30% (v/v) (3 days) Tannins (2.35 mg/g)
E. coli, P. aureginosa, S. aureus,
A. niger and C. Albicans Paper disc diffusion method iz ≤ 15 mm. [24]





Bacteria: E. Coli, B. Subtillis,
S. aureus, and Enterobactor
Slide germination method Bacteria: MIC < 100–200 µg/mL, fungi:MIC < 2.5–10 µg/mL. [25]
India Soxhlet with Ac (8 h) -
H. bispinosa Neumann (Acarina:




At 3 mg/mL: mortality 100% H. maculate, 78%
H. bispinosa, parasite dead H. maculata
(LC50 = 0.646 mg/mL).
[26]
Nigeria
Maceration with agitation in
EtOH:H2O 20% and 80%
(v/v) (24 h)
- Trypanosoma brucei brucei andHEK293 Alamar Blue assays
At 238.10 µg/mL: IC50 (T. b. brucei) = 6.3
µg/mL and 48.9 µg/mL for 80% and 20%
extracts, respectively, IC50 (HEK293) 30.1 and
24.16%, respectively.
[27]
India Soxhlet with ethyl acetateand MeOH (8 h) - Plasmodium falciparum strains SYBR green assay
IC50 9–18 µg/mL, resistance indices = 0.6 and
1.4 in MeOH and ethyl acetate, respectively. [28]
Malaysia Hydrodistillation (3 h) - Toxoplasma gondii MTT assay with Vero cells
At 200 µg/mL: No cytotoxic effect
(EC50 = 37.54 µg/mL), anti-parasitic activity
(EC50 of 3.94 µg/mL).
[29]
India Soxhlet with EtOH, andmaceration in H2O (6 days)
-
E. coli, Shigella spp., Salmonella
spp., Aeromonas spp., S. aureus,
and Candida spp.
Agar well diffusion assay H2O: iz ≤ 30 mm (max C. albicans). EtOH:iz ≤ 31 mm (max Aeromonas hydrophila). [30]
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Table 1. Cont.
Origin Extraction Method Major Constituent Microorganisms Assay Main Results Ref.
India
Soxhlet with EtOH:H2O 70%





E. coli, Salmonella spp., and
Vibrio cholerae Agar well diffusion assay
At 1000 µg/mL: iz ≤ 30 mm. MeOH: MIC
(100%) > 250 µg/mL. EtOH:H2O:MICs (38–65%)
> 500 µg/mL and > 750 µg/mL. Ethyl acetate
and H2O: MICs > 750 µg/mL.
[31]
Bangladesh Maceration in H2O andMeOH:H2O 75% (v/v) (48 h)
- V. cholera Agar well diffusion assay
MICs = 1250 µg/mL (H2O), 850 µg/mL for




India Decoction Major component: quercetin(2 mg/g)
E. coli (heat labile (HLT) and
cholera toxin (CT)), V. cholerae,
Shigella flexneri




At 2.7 mg/mL: (EC50 = 0.98 (S. flexneri) and
2.88% (V. cholerae). ↓ adherence and invasion to
epithelial cells (EC50 = 0.37–1.25% and
0.04–0.25%, respectively). The effect on
adherence is not due to quercetin and the
invasion is lower than with the extract. ↓
Production of HLT and CT (EC50 = 1.03 and
2.69%) and binding to glioside monosialic acid
enzyme (EC50 = 0.06 and 2.51%).
[33]
Brazil Soxhlet with n-hexane, ethylacetate, MeOH, H2O (24 h)
- S. aureus, Salmonella spp., andE. coli Disc diffusion method
At 1938 µg/disc: iz = 7.00–11.25 mm (Soxhlet),
and 11–18 mm (H2O). No inhibition to E. coli
(H2O) and Salmonella spp. (hexane and
ethyl acetate).
[34]
Nigeria Soxhlet with EtOH:H2O 60%(v/v) (5 h), and H2O (3 h)
- E. coli and S. aureus Agar well diffusion assay
At 10 mg/mL: H2O: iz = 9–16 mm and 8–11
mm, MICs = 5 and 2.5 mg/mL (E. coli and
S. aureus, respectively). EtOH:H2O: iz 12–21 and
11–14 mm, MICs = 1.25 and 0.625 mg/mL,
respectively.
[35]
Japan Infusion (8 min) Tannin content: 1.11 mg/mL H1N1 virus strains 19-h Influenza growthinhibition assay
At 0.4 mg/mL: inhibition growth
(IC50 = 0.05–0.42%).
[36]
Acetone (Ac); N,N-dimethylformamide (DMF); dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); effective concentration (EC50); inhibition zone (iz); inhibitory concentration
(IC50); lethal concentration (LC50); minimum bactericidal concentration (MBC); minimum fungicidal concentration (MFC); minimum inhibitory concentration (MIC); total flavonoid
content (TFC); total phenolic content (TPC); Tetrazolium (MTT); ↑ increases the affect; ↓ decreases the effect.
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2.1.2. Neoplasms
All the results published regarding anti-cancer properties have been summarized in Table 2.
Kawakami et al. [37] evaluated the anti-proliferative activity of guava leaf extract in human-colon
adenocarcinoma cell line (COLO320DMA). These authors found that the extract depressed the
proliferation rate due to the presence of quercetin and quercetin glycosides. Moreover, different
extracts were tested on three cancer cell lines (cervical cancer (HeLa), breast cancer (MDA-MB-231),
and osteosarcoma (MG-63)). The extracts showed no anti-proliferative activity towards HeLa cells,
although they displayed activity against MDA-MB-231 and MG-63, the ether extract being the most
effective, followed by methanol and water extracts. However, ether and methanol extracts presented
a cytotoxic effect on non-malignant cell Madine Darby canine kidney (MDCK) [38]. In contrast,
an ethanol extract from the stem and leaves reported significant anti-tumor activity on HeLa and
colorectal carcinoma (RKO-AS45-1), whereas its effect was less significant for a lung fibroblast cell line
(Wi-26VA4) [39]. This difference could be due to the origin of the leaves, compounds in the steam,
or even to the extraction method selected. In this context, an organic guava leaf extract provided
molecular evidence of cytotoxic or anti-tumor activity in human breast carcinoma benign cells (MCF-7)
and also in murine fibrosarcoma (L929sA) [40]. A fact worthy to comment is that the difference
noticed in the cytotoxic effect on MDA-MB-231 cell line might be because the extraction differs [38,40].
Furthermore, the aqueous extract of budding guava leaves displayed an anti-tumor effect against
human prostate epithelial (PZ-HPV-7) and carcinoma (DU-145) cells in view of the cell-killing-rate
coefficients, as well as anti-angiogenesis and anti-migration activities, respectively [41,42].
Regarding the bioactivity of terpenes from guava, an enriched mixture of guajadial, psidial A,
and psiguadial A and B proved anti-proliferative effect for nine human cancer lines: leukemia (K-562),
breast (MCF-7), resistant ovarian cancer (NCI/ADR-RES), lung (NCI-H460), melanoma (UACC-62),
prostate (PC-3), colon (HT-29), ovarian (OVCAR-3), and kidney (786-0) [43]. The apoptotic effect of
β-caryophyllene oxide (CPO) on MCF-7 and PC-3 cell lines was also demonstrated because of its ability
to interfere with multiple signaling cascades involved in tumor genesis [44]. Moreover, the essential
oil from guava leaves exerted an anti-proliferative effect on human-mouth epidermal carcinoma (KB)
and murine leukemia (P388) cell lines [45], while a hexane fraction of the leaves showed a cytotoxic
effect against leukemia (Kasumi-1) cancer-cell line at higher half maximal inhibitory concentration
(IC50), probably due to a less concentration of the bioactive compounds of the leaves [46]. Finally,
cytotoxic and apoptotic effect in PC-3 cells and apoptotic effect in LNCaP cells was reported. The lack
of cytotoxic effect in LNCaP might be because the cell growth is androgen-dependent, while in PC-3
is androgen-independent. [47]. Comparing these data with those reported by Park et al. [44], high
concentration is needed for causing cell death, and a weak effect is found on early apoptotic cell.
The main difference between these works is the composition of the extract, so it could be concluded
that an antagonist effect is produced amongst the isolated compounds by Ryu et al. [47].
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Table 2. In vitro studies against neoplasm.
Origin Extraction Method Major Constituent Cell Line Assay Main Results Ref.
Japan Maceration in EtOH:H2O
50% (v/v)




At 1 mg/mL: ↓ human cyclooxygenase activity
(IC50 55 and 560 µg/mL PGHS-1 and 2,
respectively), ↓ IC50 5.1 µg/mL (PGSH) and
4.5 µg/mL (cyclooxygenase). [37]
At 100 µg/mL: Quercetin ↓ IC50 = 5.3 (PGSH-1)
and 250 µg/mL (PGSH-2), ↓ DNA synthesis rate.
Malaysia Soxhlet with ether,
MeOH, and H2O
-






At 10 mg/mL: HeLa: No anti-proliferative
activity.
[38]
MDA-MB-231: IC50 ether extract (4.2 µg/mL) >
MeOH (18.6 µg/mL) > H2O (55.7 µg/mL).
MG-63: same order (IC50 of 5.42, 23.25, and
61.88 µg/mL, respectively).
MDCK: cytotoxic effect of ether and MeOH
extract (IC50 = 5.03 and 11.55 µg/mL,
respectively).











and human breast cancer
(MDA-MB-231 and MCF-7)
MTT assay IC50 = 55 µg/mL (L929sA), 820 µg/mL (MCF7cells), no cytotoxic effect on MDA-MB-231 cells. [40]





At 0.25 mg/mL: cell suppression (IC50 0.57
mg/mL). ↓ Expressions of VEGF (76.9%), IL-6
(98.8%) and IL-8 (98%), and MMP-2 (100%) and
MMP-9 (100%). Suppressed the cell migration
(30.9%) and the angiogenesis.
[41]
Taiwan Decoction (1 h)
TPC: 470.0 mg/g
Individual compounds:
gallic acid (348), catechin
(102), epicatechin (60), rutin
(100), quercetin (102), and
rutin (100) in mg/g
Human prostate epithelial
(PZ-HPV-7) and DU-145 MTT assay
At 1 mg/mL: 100% suppression DU-145 cells.
PZ-HPV-7 cells followed an auto-decaying
process. Cell-killing rate coefficient (kapp) =
0.03 × 103 phenolic compounds cells/mg h.
[42]
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Table 2. Cont.
Origin Extraction Method Major Constituent Cell Line Assay Main Results Ref.
Brazil Soxhlet with DCM.Maceration with EtOH
Guajadial, psidial A, and




(UACC-62), prostate (PC-3), colon
(HT-29), ovarian (OVCAR-3), and
kidney (786-0)
Protocol established by NCI
(ELISA test)
At 250 µg/mL: Anti-proliferative activity DCM >
EtOH, inhibition growths: 26 (OVCAR-3)-65





80% (v/v) (3 h) and
isolation
CPO PC-3 and MCF-7
MTT, annexin V antibody,
TUNEL, and western blot
assays
At 50 µg/mL: ↓ cell proliferation, ↑ early and late
apoptotic effect, down-regulation of
PI3K/AKT/mTOR/S6K1 pathway, up-regulation




carcinoma (KB) and murine
leukemia (P388)
MTT assay
At 0.15 mg/mL: KB: 75% cytotoxic effect,
IC50 = 0.04 mg/mL; At 0.08 mg/mL: P388: 80%
cytotoxic effect, IC50 = 0.05 mg/mL.
[45]




80% (v/v) (3 h).
Fractionation
with hexane








MTT, annexin V antibody,
TUNEL, and western
blot assays
At 150 µg/mL: PC-3: ↑ apoptotic effect of the
hexane fraction (15%), ↓ effect on early apoptotic
cells, ↑ effect for late apoptosis, via the
suppression of PI3K/AKT/mTOR/S6K1 and
MAPK signalling cascades in both cell lines.
[47]
β-Caryophyllene oxide (CPO); c-jun NH2-terminal kinases (JNK); dichloromethane (DCM); inhibitory concentration (IC50); mammalian target of rapamycin (mTOR); mitogen-activated
protein kinases (MAPKs); phosphatidylinositol 3-kinase (PI3K); prostaglandin endoperoxide H synthase (PGHS); protein kinase B (AKT); ribosomal protein S6 kinase beta-1 (S6K1);
signal-related kinases (ERKs); tetrazolium (MTT); total flavonoid content (TFC); total phenolic content (TPC); ↑ increases the affect; ↓ decreases the effect.
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2.1.3. Diseases of the Blood and Immune System
A fermented guava leaf extract was tested in mouse macrophage (RAW 264.7) cells. The results
confirmed its potential to decrease the expression of lipopolysaccharide-inducible nitric oxide synthase
and cyclooxygenase-2 proteins level, two pro-inflammatory mediators, through the down-regulation
of nuclear factor-κB transcriptional activity (NF-κB) [48]. This biological activity was also reported in
other works [40,49,50]. Briefly, Jang et al. [49] evaluating the prostaglandin E2 production found that the
inhibitory effect was highly correlated to the total phenolic content. Kaileh et al. [40] suggested that the
suppression of the nuclear factor-κB could be at the transcriptional level because of the lack of binding
between nuclear factor-κB and DNA in murine fibrosarcoma (L929sA) and two breast-cancer cell lines
(MDA-MB231 and MCF7). At the same time, Jang et al. [50] found that the lipopolysaccharide-induced
production of nitric oxide and prostaglandin E2 was due to the ability of guava leaf extract to suppress
phosphorylation in protein expression. Moreover, Sen et al. [51] verified the inhibition of nuclear
factor-κB activation in Labeo rohita head-kidney macrophages by the flavonoid fraction of guava leaf
extract and Jang et al. [52] improved the inhibition of lipopolysaccharide-induced prostaglandin E2 and
nitric oxide production by optimizing of the extraction conditions. Furthermore, methanol and ethanol
leaf extracts also showed the inhibition of hypotonicity-induced lysis of erythrocyte membrane [53].
Meanwhile, Laily et al. [54] suggested the use of guava leaves as immune-stimulant agent because
they modulated the lymphocyte proliferation response.
The results for this activity, confirm the potential of guava leaves as an anti-inflammatory
treatment and as immune-system stimulatory agent. As is shown in Table 3, a general trend is reported
in every work, although the differences noticed in the data are probably due to the different extraction
method and to the doses assayed, or even to the harvesting time of the leaves. However, the mechanism
should be further studied since two different pathways are suggested for the down-regulation of NF-κB.
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Table 3. In vitro assays against diseases of the blood and immune system.
Origin Extraction Method Major Constituent Cells Assay Main Results Ref.
Korea Maceration in MeOH:H2O70% (v/v) (5 days) -
LPS-stimulated RAW 264.7
(Mouse macrophage)




At 125 µg/mL: no cytotoxic effect, ↑ 44–62% inhibition
rates. ↓ LPS-induced NO and PEG2 ↓ iNOS and COX-2
(↓ I-κBα degradation, ↓ activation NF-κB).
[48]
Palestine Maceration in DCM:MeOH50% (v/v) (24 h) - L929sA fibroblast
Transfection and
luciferase assays
At 62.5 µg/mL: ↓ expression of IL-6 and NF-κB luciferase
reporter gene construct via the NF-κB transactivation level,
since no ↓ inhibition of NF-κB/DNA binding.
[40]
Korea Extraction in MeOH:H2O70% (v/v) (6 h) TPC: 426.84 mg (GAE)/g LPS-stimulated RAW 264.7
MTT, Griess, and ELISA
test assays
At 30 µg/mL: no cytotoxic effect. ↓ LPS-induced NO
(52.58%) and the production of PGE2 (43.45).
[49]
Korea Extraction in EtOH:H2O55% (v/v) (4.9 h, 47 ◦C)
Gallic acid (0.2) and
catechin (4.4) in mg/g LPS-stimulated RAW 264.7
MTT, Griess, ELISA test,
RT-PCR, and total western
blot assays
At 50 µg/mL: no cytotoxic effect. ↓ LPS-induced NO
(>65%) by ↓ iNOS, ↓ PGE2 (to basal level) via ↓ COX-2
mRNA. ↓ IL-6. ↓ iNOS and COX-2 due to the
down-regulation of ERK1/2 pathway, because no effect
was found to other proteins at the dose tested.
[50]







At 200 µg/mL, ↓ LPS-induced NO (75%) by ↓
iNOS-mRNA, ↓ PGE2 (45%) via ↓ production
COX-2-mRNA, TNF-α, IL-1β, IL-10, and mRNA
expression. Suppressed phosphorylation of MAPK
(↓ I-κBα degradation ↓ activation NF-κB).
[51]
Korea Soxhlet with EtOH:H2O55% (v/v) (4.9 h, 47 ◦C)
Gallic acid (0.09) and
catechin (0.72) in mg/g LPS-stimulated RAW 264.7
MTT, Greiss and ELISA
test assays
At 30 µg/mL: no cytotoxic effect. ↓ LPS-induced NO
(47.5%) and PGE2 (45.8).
[52]
India Maceration with agitationin MeOH and EtOH (24 h) - Human blood
HRBC membrane
stabilization method




in EtOH:H2O 96% (v/v)
(6 h)
TPC: 101.93 mg GAE/g Human lymphocyte MTT assay 0.5 µg/mL: Stimulation index 1.54%. [54]
Cyclooxygenase-2 (COX-2); dichloromethane (DCM); gallic acid equivalent (GAE); human red blood cell (HRBC); inducible nitric oxide synthase (iNOS); inhibitor of kappa B (I-κBα);
interleukin-1β (I-1β); lipopolysaccharide (LPS); mitogen-activated protein kinases (MAPKs); nitric oxide (NO); prostaglandin E2 (PEG2); reverse transcription-polymerase chain reaction
RT-PCR; tetrazolium (MTT); total phenolic content (TPC); transcriptional nuclear factor-κB (NF-κB); Tumor necrosis factor alpha (TNF-α); ↑ increases the affect; ↓ decreases the effect.
Int. J. Mol. Sci. 2017, 18, 897 12 of 31
2.1.4. Endocrine and Metabolic Diseases
Several works have focused on elucidating the anti-diabetic compounds present in guava leaves
(Table 4). Although the origin of the leaves remains different, the presence of these compounds has
demonstrated the hypoglycemic effect of the leaves via different assays. However, the main mode of
action seems to be due to an inhibition of the enzymes related to this activity.
The anti-glycative potential of the guava leaves was evaluated, with the conclusion that the extract
inhibited, in vitro, the formation of advanced glycation end-products formation [55]. Moreover, the
aqueous guava leaf extract, in an albumin/glucose model system, also exerted the same effect and
indeed inhibited Amadori products. Gallic acid, catechin and quercetin exhibited over 80% inhibitory
effects whereas ferulic acid showed no activity [56]. In another study, seven pure flavonoid compounds
(quercetin, kaempferol, guaijaverin, avicularin, myricetin, hyperin, and apigenin) showed strong
inhibitory activities against sucrase, maltase, and α-amylase, and a clear synergistic effect against
α-glucosidase [57]. Moreover, Deguchi and Miyazaki [58] suggested that the component that inhibited
the in vitro activities of α-glucosidase enzymes in guava extract was a polymerized polyphenol.
In addition, polysaccharides from guava leaves also exhibited α-glucosidase inhibition [59].
Eidenberger et al. [60] demonstrated the dose-dependent inhibition of guava leaf ethanol
extracts on dipeptidyl-peptidase-IV due to the individual flavonol-glycosides: peltatoside, hyperoside,
methylquercetin hexoside, isoquercitrin, quercetin/morin pentoside, guaijaverin, and quercetin/morin
pentoside. Additionally, the individual flavonol-glycosides found in the guava extract reported
no significant differences compared with the uptake of the whole guava extract into epithelial
cells (CaCo-2) [60]. In the same cell line, the inhibition of fructose uptake was also tested by
Lee et al. [61], who confirmed that catechin and quercetin contributed to the inhibition of glucose
transporters. In addition, the enhancement of aqueous guava leaf extract was investigated with
regard to glucose uptake in rat clone 9 hepatocytes. Moreover, quercetin was proposed as the active
compound responsible for promoting glucose uptake in liver cells and contributing to the alleviation
of hypoglycemia in diabetes [62]. Furthermore, Basha and Kumari [63] also estimated the glucose
uptake of different extracts. The methanol extract of guava leaves was found to be the most efficient in
lowering glucose levels. Basha et al. [64] demonstrated the ability of guavanoic-acid-mediated gold
nanoparticles to inhibit the protein tyrosine phosphatase 1B activity.
Indeed, a guava leaf ethanol extract was tested in pre-adipocyte cell line (3T3-L1), which showed
its ability to inhibit adipocyte differentiation via down-regulation of adipogenic transcription factors
and markers, and hence may prevent obesity in vivo [65]. To evaluate the potential of the leaves on
glucose uptake and glycogen synthesis, an aqueous extract was used in insulin-resistant mouse (FL83B)
cells. The results confirmed the improved expression and phosphorylation of insulin signaling-related
proteins, promoting glycogen synthesis and glycolysis pathways. In fact, this work provides new
insights into the mechanisms through which the guava extract improves insulin resistance in the
hepatocytes [66]. In the same cell line, vescalagin was postulated as the active component that may
alleviate the insulin resistance in mouse hepatocytes [67].
In this sense, the latest study made in L6 myoblasts and myotubes cells confirmed that the
glucose uptake recruitment followed a wortmannin-dependent pathway. In addition, guava leaves
also inhibited aldose reductase activity, up-regulated gene- and protein-level expression of several
insulin receptors and also improved cellular-level glucose uptake [68].
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Table 4. Compounds in guava leaves with anti-diabetic properties in in vitro assays.
Origin Compound Assay Main Results Ref.
India Ethyl acetate fraction In vitro glycation of BSA-fluorescencemeasurement In vitro AGEs formation with IC50 of 38.95 ± 3.08 µg/mL. [55]
Taiwan Gallic acid, catechin and quercetin
In vitro glycation of BSA-fluorescence
measurement; Fructosamine assay
and Girard-T assay
At 100 µg/mL: 80% inhibitory effects on the formation of α-dicarbonyl
compounds at a concentration of 50 µg/mL, inhibitory effects on AGEs
formation in BSA glycation systems.
[56]
China Quercetin, kaempferol, myricetin




At 1.5 mg/mL: inhibitory activities with IC50 values of 3.5, 5.2 and 3.0 mM
against sucrase, with IC50 values of 4.8, 5.6 and 4.1 mM against maltase and
with IC50 values of 4.8, 5.3 and 4.3 mM against α-amylase, respectively.
Synergistic effect against α-glucosidase.
[57]
China Water-soluble polysaccharides,including GP90 and P90 α-Glucosidase inhibition assay
α-Glucosidase inhibition activity with an EC50 of 2.27 µg/mL and
0.18 mg/mL. [59]
- Peltatoside, hyperoside, isoquercitrin,guaijaverin and flavonol-glycosides
Spectrophotometric assay; absorption
assay into CaCo-2 cells
Concentration of the compounds (0.01 to 0.06 µmol/mL). Individual
flavonol-glycosides inhibited DP-IV dose-dependently. The ethanolic guava
leaves extract (380 µg/mL) showed a dose-dependent inhibition of DP-IV,
with an IC50 of 380 µg/mL test assay solution; the highest uptake was
from Guaijaverin.
[60]
Korea Quercetin and catechin Fructose transport in CaCo-2 cellsystems
At 1 mg/mL: inhibition of fructose uptake (55%). At 30 µg/mL: quercetin
contributed to both, GLUT2 and 5 transporters, and catechin to
GLUT5-mediated fructose uptake inhibition.
[61]
India Guavanoic acid Spectrophotometric assay
At 27 µg/mL: remarkable PTP1B inhibitory activity (90%) and in vitro stability
in various physiological medium including saline, histidine, cysteine, BSA,
HSA and buffers (pH 5, 7 and 9). IC50 = 1.14 µg/mL.
[64]
India n-Hexane, methanol, ethanol andaqueous leaf extracts Inhibitory glucose diffusion
At 50 g/L: the methanol extract was the most potent with the lowest mean
glucose concentration of 201 ± 1.69 mg/dL at the end of 27 h (↓ 93% uptake). [63]
Japan 70% Ethanol extract Oil Red O Assay; Real-Time RT
At 100 µg/mL: inhibition of 3T3-L1 differentiation via down-regulation of
adipogenic transcription factors and markers (mRNA levels of PPAR-γ,
C/EBP-α, and aP2), and suppression of mitotic clonal expansion
(at day 4 and 8).
[65]
Taiwan Aqueous extract Glucose uptake test; bicinchonic acidmethod; Western-blot analysis
At 400 µg/mL: ↑ IR (25.1%), p-IR (46.2%), p-IRS (51.2%), PI3K (32.2%), Akt
(46.1%), p-Akt (36.3%), GLUT-2 (46.8%), and total glycogen synthase (45.5%). [66]
Taiwan Vescalagin Glucose-uptake test At 100 µg/mL: Enhancement of glucose uptake in TNF-α-inducedinsulin-resistant. [67]
Advanced glycation end products (AGEs); bovine serum albumin (BSA), dipeptidyl peptidase (DP); effective concentration (EC50); glucose transporter 2 and 5 (GLUT-2; GLUT-5); human
serum albumin (HSA); inhibitory concentration (IC50); insulin receptor (IR); insulin receptor substrate (p-IRS (Tyr)); p85 regulatory subunit of phospho-inositide 3 kinase (PI3K (p85));
phosphorylation of the insulin receptor (p-IR (Tyr)); protein kinase B (p-Akt (Ser)); tumor necrosis factor (TNF); ↓ decreases the effect.
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2.1.5. Diseases of the Circulatory System
Cardiovascular disorders have been related to the endothelial cell damage that causes
atherosclerosis. In this sense, extracts from budding guava leaves demonstrated a protective,
in vitro, effect in bovine aortal endothelial cells, delaying low-density lipoprotein oxidation and
preventing oxidized low-density lipoprotein cytotoxicity [69]. A similar effect was also noted in human
umbilical-vein endothelial cell due to the ability of saving cell-viability reduction, suppressing reactive
oxygen species production and nitric oxide release, as well as inhibiting the expression of NF-κB [70].
Moreover, budding guava leaves also showed their ability as an anticoagulant in plasma, since they
reduced thrombin clotting time and inhibited the activity of antithrombin III. Thus, they could help to
reduce the development of cardiovascular complications [71].
In addition, flavonoids and phenolic acids in the leaves could contribute to the prevention and
amelioration of gout and hypertension, since, in rat-tissues homogenates, they inhibit the activity
of two enzymes related to the development of both diseases (xanthine oxidase and angiotensin
1-converting enzymes) [72].
2.1.6. Diseases of the Digestive System
Guaijaverin, isolated from guava leaves, displayed high inhibitory activity against
Streptococcus mutans. In fact, guaijaverin exhibited its ability as an anti-plaque agent, becoming
an alternative for oral care [73]. Furthermore, guava leaves showed greater bactericidal effect on
early (Streptococcus sanguinis) and late (S. mutans) colonizers compared to Mangifera indica L. and
Mentha piperita L. leaves, whereas, when they are compared with the plant extract mixture, the effect is
slightly lower. By contrast, guava leaves showed similar and higher anti-adherence effect than the
plant mixture [74]. In another study, the whole extract was tested on the cell-surface hydrophobicity of
selected early settlers and primary colonizers of dental plaque, showing its ability to alter and disturb
the surface characteristics of the agents, making them less adherent [75–77], and also delayed in the
generation of dental biofilm by targeting growth, adherence, and co-aggregation [78]. This property
could be due to the presence of flavonoids and tannins detected in P. guajava [79]. Shekar et al. [80]
also confirmed the use of the leaves as anti-plaque agents against Streptococcus mutans, S. sanguinis,
and S. salivarius. Kwamin et al. [81] discovered the effectiveness of guava leaf extract in the leukotoxin
neutralization of Aggregatibacter actinomycetemcomitans, leading it to be considered as a possible
agent for the treatment of aggressive forms of periodontitis. In addition, extracts rich in guava
flavonoids have demonstrated their potential for preventing dental caries due to the growth inhibition
of the oral flora [82]. Moreover, its soothing of toothache has been verified based on the analgesic,
anti-inflammatory, and anti-microbial activity properties [83] and it has been reviewed positively as an
adjutant for treating periodontal disease [84].
Concerning the liver disorders, the cytotoxic and hepato-protective effects of guava leaves were
reported. Studies carried out in clone 9 cells treated with different extracts of the leaves showed that
only ethanol and acetone extracts tend to have cytotoxicity effect at high concentrations. Moreover,
the ethanol extract showed hepato-protective activity, although the hot-water extract reported greater
effect and lower cytotoxicity [85].
Table 5 compiles the methodology followed and the results reported in the present works. It is
important to keep in mind that the origin, the selection of the extraction method or solvent, and the
concentration of the extract tested generally provide different data. For example, comparing data
for inhibition zones, best results are noticed at long maceration time in acetone, which seems to be
a better extracting solvent than ethanol [77,78,80,82]. Hydrophobicity depends on the origin of the
leaves, the extraction method, and the concentration of the extract tested, and it also depends on the
lipophilic (index > 70%) or hydrophilic nature of the strain [73,75,79]. Finally, minimum inhibitory
concentration relies on all factors.
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Table 5. In vitro assays against diseases related to the digestive system.
Origin Extraction Method Microorganism(s)/Cells Assay Main Results Ref.
India Soxhlet with MeOH (4.5 h) S. mutans strains
Agar well diffusion assay, effect on acid
production, on sucrose-dependent
adherence to smooth glass surfaces, and
on sucrose-induced cellular aggregation,
and MATH assays
MIC > 5 mg/mL (MeOH). MIC = 2–4 mg/mL (guaijaverin)
At sub-MIC (0.125–2 mg/mL): ↑ pH (5 to 6–7), hydrophobicity indexes (3.2–72%),
↓ sucrose-dependent adherence (34–84%) and aggregation.
[73]
Malaysia Decoction S. sanguinis and S. mutans NAM model system
At 60.95 mg/mL: MIC = 7.62 (S. sanguinis) and 3.81(S. mutans.) mg/mL. MBC
values = 15.24 and 30.48 mg/mL, respectively. At 0.5 mg/mL: ↓ adherence 57 and
60% (single-species) and 88–89% (dual-species).
[74]
Malaysia Sonication with H2O (10 min)
S. sanguinis, S. mitis, and
Actinomyces spp. MATH assay
At 1 mg/mL: ↓ 54.1%, 49.9% and 40.6%, respectively, cell-surface hydrophobicity.
At 20 mg/mL: was 64.7, 60.5, and 55.5%, respectively. [75]
Malaysia Decoction S. sanguinis, S. mitis, andActinomyces spp.
Bacterial growth and generation time
rates determinations
At 4 mg/mL: Time growth = 1.22 (S. sanguinis, Actinomyces spp) and 2.06 h
(S. mitis) ↓ growth 42.6%, 51.2% and 55%. [76]
India Maceration with stirring in EtOH(2 days)
S. mutans, S. sanguinis, and
S. salivarius Agar well diffusion assay At 10 mg/mL: inhibition zones of 21.17, 18.58, and 23.00 mm, respectively. [77]
India
Maceration (2 days) and Soxhlet
(6 h) with EtOH, H2O, and
EtOH:H2O 50% (v/v)
S. mutans and S. mitis
Agar well diffusion assay,
sucrose-dependent adherence and
cellular co-aggregation activities, and
biofilm formation sterile acrylic tooth
determinations
At 15 mg/mL: inhibition zone for H2O (11.8 mm) to EtOH:H2O (25 mm), both by
Soxhlet. MIC = 1 mg/mL.
EtOH:H2O extract: at >0.05 mg/mL: ↓ adherence and co-aggregation, at MIC,
↓ the viable count of dental biofilm (3.50 log10 CFU/mL).
[78]
India Soxhlet with EtOH:H2O 50% (v/v)(6 h) S. mutans and S. mitis MATH assay At >1 mg/mL ↓ hydrophobicity (index < 40%). [79]
India Maceration with stirring (2 days)and Soxhlet with EtOH
S. mutans, S. sanguinis, and
S. salivarius Agar well diffusion assay At 10 mg/mL: ↑ inhibition zones for maceration extracts (19–23 mm). [80]
Ghana Maceration with agitation inEtOH:H2O 70% (v/v) (24 h)
Aggregatibacter
actinomycetemcomitans strains
Agar well diffusion assay, release of the
cytosol enzyme lactate dehydrogenase,
fluorescence assisted cell sorter, and
ELISA assays
No growth inhibitory effect, although neutralized the cell death and
pro-inflammatory response, and restored the morphological alterations induced
by the leukotoxin. These effects were due to the direct binding of guava
compounds and the leukotoxin.
[81]
India
Maceration in Ac, EtOH,
chloroform, MeOH and H2O
(15 days at 22 ◦C)




Agar well diffusion assay ↑ Inhibition zones in Ac (15–29 mm), except for N. catarrhalis (20 mm in MeOH). [82]
India Maceration in MeOH (72 h).Fractionation with ethyl acetate S. aureus and S. mutans
HRBC membrane stabilization method,
disc and agar well diffusion assays
MeOH and ethyl acetate fraction ↑ protection (84–99%) to the inflammatory
response. Inhibition zones (25–100 µg/mL) = 10.5 to 22 mm by both methods.
MICs = 0.48 (ethyl acetate) and 0.62 (MeOH) mg/mL.
[83]
Taiwan Maceration EtOH, Ac, H2O (roomtemperature and 60 ◦C) (24 h) Clone 9 rat liver cells WST-1 and ALT assays
At >500 µg/mL cytotoxic effect of EtOH and Ac and 600 µg/mL for H2O.
At <200 µg/mL normal values were observed for H2O and Ac, and EtOH
(<500 µg/mL).
At <100 µg/mL: Hepato-protective effect in EtOH and H2O (full range).
[85]
Alanin aminotransferase (ALT); colony forming unit (CFU); human red blood cell (HRBC); microbial adhesion to hydrocarbon test (MATH); minimum bactericidal concentration (MBC);
minimum fungicidal concentration (MFC); minimum inhibitory concentration (MIC); nordini’s artificial mouth (NAM); Tetrazolium (WST-1); ↑ increases the affect; ↓ decreases the effect.
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2.1.7. Diseases of the Skin and Subcutaneous Tissue
Qa’dan et al. [86] described the antimicrobial effect of a leaf extract against the main developer of
acne lesions, Propionibacterium acnes, and other organisms isolated from acne lesions. The antimicrobial
activity was also displayed against pathogenic bacteria associated with wound, skin, and soft-tissue
infections [87]. Furthermore, antifungal properties have also been studied by Padrón-Márquez et al. [88].
The acetone and methanol extracts displayed relevant activity against dermatophytic fungi, and thus
could be considered as new agents against skin disease. Furthermore, phenols from the leaves were
tested on human-skin fibroblast cells and showed antifungal properties [89].
In addition, the tyrosinase inhibitory activities of 4 different parts (branch, fruit, leaf, and seed)
of guava, extracted with acetone, ethanol, methanol, and water were tested by You et al. [90] who
reported that the ethanol extract from the leaves reached the highest activity. Therefore, the leaves
might be appropriate for both boosting the whitening of skin and inhibiting browning. In addition,
in a human keratinocyte cell line, an ethyl acetate extract showed a positive effect on atopic dermatitis
via the inhibition of cytokine-induced Th2 chemokine expression [91].
Lee et al. [92] carried out the first electrophysiological study based on ultraviolet (UV)-induced
melanogenesis with guava leaves. The authors suggested the use of guava leaves for both direct and
indirect prevention of skin melanogenesis caused by UV radiation. In fact they demonstrate that
methanolic guava leaves extract inhibits tyrosinase, that is the key enzyme in melanin synthesis, and
ORAI1 channel that has shown to be associated with UV-induced melanogenesis.
2.1.8. Other Activities Related to Several Diseases
An aqueous guava extract showed its ability to decrease the radiolabeling of blood constituent
due to an antioxidant action and/or because it alters the membrane structures involved in ion transport
into cells [93]. Guava leaves also have been demonstrated to possess anti-allergic effects in rat mast
(RBL-2H3) cell line by the inhibition of degranulation and cytokine production, as well as blocking
high-affinity immunoglobulin E-receptor signaling [94].
2.2. In Vivo Studies
2.2.1. Infectious and Parasitic Diseases
After checking the effect of guava leaf extract, in vitro, against Aeromonas hydrophila, in vivo
experiments were carried out in tilapia (Oreochromis niloticus), indicating the potential use of P. guajava
as environmentally friendly antibiotic [95]. The leaves also had anti-viral and anti-bacterial activity
towards shrimp (Penaeus monodon) pathogens such as yellow-head virus, white spot syndrome virus,
and Vibrio harvey. In addition, guava leaf extract improved the activities of prophenoloxidase and
nitric oxide synthase in serum, and of superoxide dismutase, acid phosphatase, alkaline phosphatase,
and lysozyme in serum and hepatopancreas [96].
Furthermore, guava leaves have been suggested for managing sleeping sickness, since they
exhibited trypanocidal effect in albino rats [97]; the extract ameliorate the tissue-lipid peroxidation
associated to trypanosomosis, as well as raising the level of the glutathione concentration [98]. The
leaves also showed anti-malarial effect in BALB/c mice infected with Plasmodium berghei via parasitemia
suppression [99]. Moreover, guava leaves are also recommended for treating infectious diarrhea since
they prevented intestinal colonization of Citrobacter rodentium in Swiss albino mice [100]. In chicks,
guava leaf extract enabled the control of diarrhea produced by E. coli and reduced the severity of its
symptomatology [101]. In mice, the improvement of cholera symptoms caused by V. cholerae, a human
pathogen, was also confirmed by Shittu et al. [102].
In addition, anti-helminthic properties towards gastro-intestinal nematodes have been found, as a
result of the presence of condensed tannins in the guava plant, which raised the levels of hemoglobin,
packed cell volume, total protein, globulin, glucose, and calcium, and lowered the levels of blood urea [103].
All the results published regarding in vivo anti-bacterial properties have been summarized in Table 6.
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Table 6. In vivo anti-bacterial effect.
Origin Extraction Method Subject Treatment Main Results Ref.
Thailand Maceration in H2O, EtOH, andether (24 h) Oreochromis niloticus Aeromonas hydrophila LD50 = 3.44 × 106 CFU/mL. ↓Mortality of the subjects. [95]
China - Penaeus monodon
Yellow-head virus, white
spot syndrome virus, and
Vibrio harveyi
Survival rate = 80–95% (↑Weight (2 to 6 g)). In serum (↑ feed): ↓ PO (7.50 U/mL) and
SOD (178.33 U/mL), ↑ NOS (64.80 U/mL). In hepato-pancreas: ↑ SOD (57.32 U/mg),
ACP (23.28 U/mg), AKP (19.35 U/mg), and LSZ (3459.946 U/mg).
[96]
Nigeria Maceration with agitation inEtOH:H2O 80% (v/v) (24 h)
Albino rats T. b. brucei At 300 mg/kg: ↓ parasitemia; ↑ survival in 24 days. [97]
Nigeria Maceration with agitation inEtOH:H2O 80% (v/v) (24 h)
Albino rats T. b. brucei
Administration 1–7 days. ↑ GSH: liver (5.4 to 8.1), kidney (3.3 to 6.0), and serum
(0.8 to 2.4), restored in kidney and serum. In the brain, no effect was found. ↓MDA:
serum (13.9 to 5.9), brain (42.8 to 18.1), kidney (27.3 to 17.6), and liver (38.2 to 19.2).
[98]
India Decoction of the leaves (10 min) BALB/c mice Plasmodium berghei At 350 and 1000 mg/kg ↓ parasitemia (73.7% and 85.8%); ↑ survival 15 and 18 days. [99]
India Extraction in EtOH:H2O50% (v/v) Swiss mice Citrobacter rodentium
At 300 mg/kg: ↓ infection (day 4) of the treatment, and no infection at day 19 (control
group at day 24). [100]
Nigeria Hidrodistillation andfractionation with ethyl acetate
ISA brown male
chicks E. coli
At 100 mg/kg: In 10 days ↓ signs of villous collapse (stunting, matting and fusion of
villi), number of wet droppings (12-6); ↑ activity, weight gaining, and feed intake
(from 27 to 45 g) in contrast to the infected ones (from 30 to 18 g); ↓ bacterial shedding
load (from 60 to 45 CFU/mL).
[101]
Nigeria Decoction of the leaves Adult mice V. cholera
At 250 mg/kg: Histopathological observations: mild degenerative, secretory, and
inflammatory changes with goblet cells and with most of the exudate (neutrophils
and lymphocytes).
[102]
India - Adult male goat Haemonchus contortus
90 Days feeding: ↑ Hb (7.2 to 8.6 g/dL), PCV (20.2 to 29.3%), total protein
(4.8 to 6.3 g/dL), GLO (2.3 to 3.8 g/dL) (↑ control (2.8)), glucose (43.9 to 52.6 g/dL),
and calcium (8.7 to 9.6 mg/dL); ↓ blood urea (47.9 to 29.8 mg/dL) (↓ control (41)).
Phosphorus balance, serum albumin levels and serum enzyme activity did not
show variation.
[103]
Acid phosphatase (ACP); alkaline phosphatase (AKP); colony forming unit (CFU); globulin (GLO); glutathione (GSH); hemoglobin (Hb); lysozyme (LSZ); malondialdehyde (MDA);
median lethal dose (LD50); nitric oxide synthase (NOS); packed cell volume (PCV); prophenoloxidase (PO); superoxide dismutase (SOD); ↑ increases the affect; ↓ decreases the effect.
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2.2.2. Neoplasms
Only one study is available on the anti-tumor effect that could be related to the phenolic
composition of guava leaves. An ethanol extract of the leaves was administrated to B6 mice after
inoculation of melanoma cells. The results suggested that the extract had a vaccine effect, but not a
therapeutic effect, against tumors through by depressing T regulatory cells [104].
Moreover, the meroterpene-enriched fraction of guava leaves, containing guajadial, psidial A, and
psiguadial A and B, was evaluated in vivo in a solid Ehrlich murine breast-adenocarcinoma model.
The results suggested that these compounds may act as phytoestrogens, presenting tissue-specific
antagonistic and agonistic activity on estrogen receptors [43]. These data partially confirmed the
results in vitro obtained by Ryu et al. [47].
2.2.3. Diseases of the Blood and Immune System
Among blood diseases, anemia indicates a failure in the immune system. In this sense, guava
extract presented an anti-anemic effect in trypanosomosis-infected Wistar rats, improving the values
of hemoglobin, packed cell volume, red-blood cell counts, mean corpuscular volume, and mean
concentration hemoglobin count while decreasing white-blood cell and neutrophil levels [105].
Moreover, the same trend in the hematological analyses was also recorded in mice. After the
administration of guava leaf extract, no alterations on the erythron were detected [106]. Nevertheless,
results differ because subjects under study are different, also the duration of the treatment, the
extraction method and the dose assayed (Table 7).
The anti-inflammatory response of the leaves was dose-dependent in induced hyperalgesia in
Sprague-Dawley rats, decreasing in paw-withdrawal latency, and significantly improving the survival
rate of mice with lethal endotoxemia [50]. Moreover, the anti-inflammatory activity of aqueous and
acetone–water extracts of the leaves was also confirmed in Swiss mice by reducing the amount of
leukocyte migration. The acetone–water extract also exhibited peripheral analgesic activity, probably
by blocking the effect or the release of endogenous substances that excite pain-nerve endings [19].
The analgesic effect in albino rats was also reported. The ethanol extract reduced the writhing
response [107], and a jumping response was found after the administration of a distilled extract
(combination of methanol and aqueous extracts) [108]. In this case, the writhing response for both
Swiss mice and Wistar rats seems to be comparable, although the dose assayed is completely different
(Table 7).
2.2.4. Endocrine and Metabolic Diseases
Guava leaves have shown their potential against one of the diseases with the highest incidence
level worldwide, diabetes mellitus, and also towards biochemical changes caused by the disease.
In spite of being leaves from different countries, treatments in different subjects or even different data,
the same trend is followed in these works (Table 8).
The effect of aqueous guava leaf extract was investigated in rabbits, fed a high-cholesterol
diet. Treatment with guava leaves reduced the plasma-cholesterol level, caused a remarkable spike
in high-density lipoprotein, a dip in low-density lipoprotein levels, and significantly reduced the
associated hyperglycemia. In addition, the extract showed hypolipidemic and hypoglycemic potentials
in hypercholesterolemic rabbits [109]. Furthermore, guava leaves reduced oxidative stress induced by
hypercholesterolemia in rats [110].
In addition, the anti-diabetic effect was also evaluated in Leprdb/Leprdb mice and significant
blood-glucose-lowering effects were observed. In addition, histological analysis revealed a significant
reduction in the number of lipid droplets, which, furthermore, at least in part, could be mediated via
the inhibition of protein tyrosine phosphatase 1B [111].
Int. J. Mol. Sci. 2017, 18, 897 19 of 31
Table 7. In vivo studies against diseases of the blood and immune system.
Origin Extraction Method Subject Treatment Main Results Ref.
Nigeria
Maceration with agitation
in EtOH:H2O 80% (v/v)
(24 h)
Wistar rats T. b. brucei/no infected
Treatment (1–7 days) at 150 mg/kg: ↑ Hb (6.5 to 10.7 g/dL), PCV (28.6 to 34.4%), RBCC
(4.1 to 5.0 × 1012/L), MCV (53.6 to 64.3 fL), and MCHC (21.4 to 31.4 g/dL); ↓WBC
(23.2 to 19.4 × 109/dL) and neutrophil levels (28.9 to 27.3 × 103/mL).Compared to no
infected subjects: similar values that obtained in treated-infected animals but with
opposite conclusions.
[105]
Nigeria Extraction in chloroform(24 h) Mice No infected
Treatment (28 days) at 45.9 mg/mL: no differences in Hb (12 to 11 g/dL), PCV (37 to 35%),
RBCC (6.1 to 5.1 × 106/L), and MCHC (33 to 32 g/dL), and neutrophil levels (13 to 12%);
↑ lymphocyte levels (85 to 92%) and MCV (61 to 69 fL).
[106]






At 400 mg/kg: PWL restored; ↑ 67% survival rate (72 h) by ↓ TNF-α (500 to 325 pg/mL)
and IL-6 (80 to 58 ng/mL). [50]
Brazil
Turbo-extraction in water




acid-induced abdominal writhing and
hot plate test
At 50mg/kg: number of leukocyte migration into the peritoneal cavity H2O < H2O
-acetone extract. No central analgesic activity. Peripheral analgesic activity: ↓ number
writhing response (from 50 to 15 count).
[19]
India Maceration in EtOH(7 days) Wistar rats Acetic acid-induced writhing
At 2 mg/kg ↓ 66% number writhing response (from 67 to 54 count). Comparable to
diclofenac sodium (75%). [107]
India Distillation with MeOHand H2O
Wistar rats Acetic acid-induced writhing and hotplate test
At 10 and 30 mg/kg ↓ responses time (at 9.4 and 10.6 s) compared to the analgesic drug
Pentazocine (14 s). [108]
Hemoglobin (Hb); interleukin-6 (IL-6); lipopolysaccharide (LPS); mean concentration hemoglobin count (MCHC); mean corpuscular volume (MCV); packed cell volume (PCV); paw
withdrawal latency (PWL); red-blood cell counts (RBCC); tumor necrosis factor alpha (TNF-α); white-blood cell (WBC); ↑ increases the affect; ↓ decreases the effect.
Int. J. Mol. Sci. 2017, 18, 897 20 of 31
Table 8. Endocrine and metabolic in vivo assays with guava leaves.
Origin Subject Treatment Main Results Ref.
Nigeria Rabbits High-cholesterol diet At 250 mg/kg: ↓ TC (15%); ↑ HDL (69%); ↓ LDL (74%); ↓ hyperglycemia 43%. [109]
Brazil Wistar rats High-cholesterol diet
At 369.89 mg phenolic compound in the extract/g: ↓ TC (29–35%), TG (59–73%); ↑ HDL
(46%); ↓ VLDL+LDL; ↓ enzyme activity (SOD (6.2 to 5.7 U/mg protein), GP





Diabetes spontaneous mutation At 10 mg/kg: 87% inhibition PTP1B; ↓ glucose levels 31% and 42% respectively. [111]
Iran Wistar rat Streptozotocin-induced diabetes
At 1mg/L: ↓ Ca/Mg ratio (18 to 12), glucose level, TG (100 to 65 mg/dL), TC
(68 to 48 mg/dL), ↑ HDL (18 to 40 mg/dL), ↓ LDL, and VLDL to normal levels; ↓
alteration in vascular reactivity (110 to 50 mmHg).
[112]
Taiwan Sprague-Dawley rats Low-dose streptozotocin andnicotinamide-induced diabetes
At 400 mg/kg: ↓ blood glucose level (230 to 140 mg/dL); ↑ plasma insulin level and
glucose utilization (normal levels); ↑ enzyme activity (hepatic hexokinase (8 to 11 U/mg
protein), phosphofructokinase (18 to 25 U/mg protein) and glucose-6-phosphate
dehydrogenase (11 to 25 U/mg protein).
[113]
India Sprague-Dawley rats Streptozotocin-induced diabetes
At 100 mg/kg: ↓ blood glucose level (4 to 1 mg/mL) and lipid peroxidation
(2 to 1 mmol/100 g tissue); ↑ enzyme activity (CAT (6 to 10 × 103 U/mg protein), SOD
(6 to 10 U/mg protein), GPx (0.4 to 0.6 U/mg protein), GRd (0.1 to 0.3 U/mg protein).
[55]
Nigeria Albino rats Alloxan-induced diabetes At 200 mg/kg: ↑ average weight (99 to 209g); ↓ blood glucose level (15 to 8 mmol/L);↓ alanine aminotransferase activity (32 to 24 U/L). [114]
India Albino rats Alloxan-induced diabetes At 500 mg/kg: ↓ blood glucose level, TC (231 to 163 mg/dL), TG (133 to 69 mg/dL),LDL (186 to 126 mg/dL), VLDL (26 to 13 mg/dL); ↑ HDL (18 to 23 mg/dL). [115]
Nigeria Wister rats - At 150 mg/kg: ↑ ALP (300, 175and 650 IU), AST (500, 400, 450 IU), ALT (1200, 1200,1800 IU), ACP (750, 650, 900 IU) activity in the kidney, liver, and serum, respectively. [116]
Nigeria Mice - At 49.3 mg/mL: ↑ AST (93 to 126 iµ/L), ALT (30 to 35 iµ/L), ALP (57 to 66 iµ/L),conjugate bilirubin (0.2 to 0.3 mg/dL) and creatinine (0.9 to 1.2 mg/dL). [106]
Nigeria Albino rats - At 150 mg/kg: ↑ serum urea (2.9 to 6 mmol/L) and creatinine (2.7 to 4 mmol/L);↓ concentration of serum Na+ (122 to 99 mmol/L). [117]
acid phosphatase (ACP); alanine aminotransferase (ALT); alkaline phosphatase (ALP); aspartate aminotransferase (AST); catalase (CAT); glutathione peroxidase (GPx); glutathione
reductase (GRd); high-density lipoprotein (HDL) cholesterol; low-density lipoprotein (LDL) cholesterol; protein tyrosine phosphatase 1B (PTP1B); superoxide dismutase enzyme (SOD);
total cholesterol (TC); triglycerides (TG); very low-density lipoprotein (VLDL) cholesterol; ↑ increases the affect; ↓ decreases the effect.
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In streptozotocin-induced diabetic rats, the administration of oral doses of aqueous and ethanol
extracts from guava leaves could alter the Ca:Mg ratio [112]; however, in low-dose streptozotocin and
nicotinamide-induced Sprague-Dawley diabetic rats, long-term administration of guava leaf extracts
raised the plasma-insulin level, the glucose utilization, and the activity of hepatic enzymes [113].
Moreover, the leaves also lowered blood glucose levels and decreased protein glycation [55].
In agreement with the above, a lower blood-glucose level was also reported in alloxan-induced
diabetic rats. Additionally, no side effects were observed in certain liver enzymes (alkaline
phosphatase and aspartate aminotransferase) whereas alanine aminotransferase activity declined [114].
In alloxan-induced diabetic rats, a decrease was also found in blood glucose, total cholesterol,
triglycerides, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, and a
significant increase in high-density lipoprotein cholesterol after 21 days of treatment with guava leaf
ethanolic extract [115].
Among the works that evaluated only biochemical parameters, guava leaf extract promoted
changes due to an alteration on the activity of alkaline phosphatase, aspartate aminotransferase,
alanine aminotransferase, and acid phosphatase in the kidney, liver, and serum [106,116]. In addition,
Adeyemi and Akanji [117] evaluated the effect of daily administration of guava leaves, demonstrating
the alteration of the serum homeostasis and the pathological variations in rat tissues.
2.2.5. Diseases of the Circulatory System
Ademiluyi et al. [118] assessed the lipid peroxidation in rats after checking the antihypertensive
effect, in vitro, of red and white guava leaves. The work concluded that the activity may be related to
rosmarinic acid, eugenol, carvacrol, catechin, and caffeic acid since they were the major constituents
of their extracts. In addition, this activity was supported by the biphasic and contractile effect on rat
vascular smooth muscles [119,120].
In addition, atherosclerosis development was reduced in apoE-knockout mice by guava leaf
extracts. In fact, the effect was connected to the presence of ethyl gallate and quercetin [121,122].
In streptozotocin-induced diabetic rats, vascular reactivity to vasoconstrictor agents was reduced,
as was vessel atherosclerosis [112]. Furthermore, Soman et al. [123] found that an ethyl acetate
fraction of guava leaves reduced cardiac hypertrophy in streptozotocin-induced diabetic rats due to an
anti-glycative effect.
2.2.6. Diseases of the Digestive System
In the digestive system, formed by the gastrointestinal tract plus the group organs necessary for
the digestion, guava leaves have demonstrated activity towards different parts.
On the one hand, the leaves have shown the ability to protect the stomach against ulceration by
inhibiting gastric lesions, reducing gastric secretory volume, and acid secretion, and raising the gastric
pH [124–126]. This anti-ulcer activity, resulting from the protection of the mucosa, was related to the
flavonoids in the leaves [127]. Despite of the subject employed for the assay, similar data are reported
in these works (Table 9). The anti-diarrheal activity of guava leaf aqueous extract was evaluated on
experimentally induced diarrhea in rodents. The extract performed in the same way as the control
drugs, offering protection, inhibiting intestinal transit, and delaying gastric emptying [128]. Another
study attributed this activity to a dual action between the antimicrobial effect and the reduction
in gastrointestinal motility ability of the extract [129]. In rabbits, the anti-spasmodic effects were
connected to a calcium channel blocking activity, which explains the inhibitory effect on gut motility.
The anti-diarrheal protection was also tested in mice [130]. As is shown in Table 9, the anti-diarrheal
activity is dose-dependent, although the protection varied depending on the subjects.
On the other hand, guava leaves exhibited hepato-protective effect due to the reduction of serum
parameters of hepatic enzymes markers and histopathological alterations in the acute liver damage
induced in rats [131–135]. Here, a dose-dependent effect is also found. However, decoction of the leaves
seems to be the best option for the extraction of the compounds that exhibited this activity (Table 9).
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Table 9. In vivo assays for digestive system related diseases.
Origin Extraction Method Subject Treatment Main Results Ref.
India Extraction with MeOH Wistar rats ASP, PL, and EtOH-induced ulcers
At 200 mg/kg: PL-induced ulcers: ↓ 64% ulcer formation (ui = 2.1), ↓ GV (5 to 2 mL),
acid secretion (88 to 64 mEq/L/100 g), ↑ pH (2 to 5).Comparable to omeprazole; ASP
(↓ 70.5%, ui = 2.5) and EtOH (↓ 70.4%, ui = 8.7)-induced systems.
[124]
Nigeria Maceration in H2O (24 h) Albino rats EtOH-induced ulcers At 1000 mg/kg: ↓MNL (9.4 to 2) ui (4.7 to 1). [125]
Nigeria Maceration with agitation inMeOH (24 h) Wistar rats EtOH-induced ulcers At 1000 mg/kg: ↓ ui (17.7 to 6.3), ↑ protection (64.4%). [126]
India Maceration in EtOH:H2O 90% (v/v)(72 h). Wistar rats PL and EtOH-induced ulcers
At 200 mg/kg: PL-induced: ↓ ulcer formation (77 to 84%), ui (5 to 1.3), GV
(1.4 to 0.5 mL/100g), and acid secretion (28 to 23 mEq/L); ↑ pH (2.0 to 3.4).
EtOH-induced: ↓ (63% to 79%, ui = 1.6 to 5.6), and gastric lesions (5.6–1.9).
[127]
South Africa Maceration in H2O (48 h)
Wistar rats and
BALB/c mice
Castor oil-induced diarrhea and
castor oil-induced enteropooling
At 400 mg/kg: ↑ 83.3% rat protection, ↓ 75% fluid accumulation in rats; ↓ 87.73%
transit in rats and 77.2% in mice; ↓ 64.35% of contractions in mice. [128]
Nigeria Soxhlet with EtOH:H2O 70% (v/v) Wistar rats Castor oil-induced diarrhea At 80 mg/kg: ↓ 53.03% transit in rats and ↓ 67.70% intestinal contractions. [129]
Pakistan Maceration with EtOH BALB/c mice,rabbit jejunum
Castor oil-induced diarrhea,
K+-induced motility
At 1 g/kg: ↑ 81.1% mice protection; Spasmolytic effect (0.3–1 mg/mL) ↓ spontaneous
contractions EC50 = 0.66 mg/mL in rabbits.
[130]
India Decoction (1 h) Wistar rats CCl4, PCM, and TAA-induced liverinjury
At 500 mg/kg: CCl4: ↓ ALT (384 to 17 U/L), AST (642 to 152 U/L), ALP (750 to 489
U/L), and bilirubin (1.6 to 0.3 mg/dL), ↓ control levels; PCM: ↓ ALT (384 to 87 U/L),
AST (642 to 179 U/L), ALP (750 to 338 U/L), and bilirubin (1.6 to 0.6 mg/dL); TAA: ↓
ALT (337 to 32 U/L), AST (438 to 237 U/L), and ALP (770 to 479 U/L).
[131]
India Soxhlet with EtOH Wistar rats PCM-induced liver injury
At 400 mg/kg: ↓ SGOT (475 to 370), SGPT (158 to 128), ALP (814 to 729), and bilirubin
(0.7 to 0.6); ↑ total protein (5.15 to 5.6), albumin (2.6 to 3.1), and GLO (2.1 to 2.4).
Histopathological observations: less diffuse granular degeneration and mild
periportal lymphocytic infiltration.
[132]
India Decoction (1 h) Wistar rats Acetaminophen-induced liverinjury
At 500 mg/kg: ↓ AST (121 to 77 IU/L), ALT (80 to 57 IU/L), ALP (115 to 67 IU/L),
and total bilirubin (4 to 2 mg/dL). Restored: total protein (5 to 7 g/dL), LPO
(7 to 2 nmol/mg protein), GPx (13 to 19 µmol/mg protein), GSH (15 to 23 µmol/mg
protein), CAT (14 to 24 µmol/mg protein), and SOD (48 to 63 µmol/mg protein).
Histopathological observations: normal lobular structure.
[133]
Egypt Maceration with agitation inEtOH:H2O 70% (v/v) (24 h)
Albino rats CCl4-induced liver injury
At 500 mg/kg: ↓ ALT (94 to 55 U/mL), AST (199 to 82 U/mL), GGT (71 to 23 U/mL),
lysosomal enzymes (50%), and LPO (7 to 3 nmol/mg protein); ↑ SOD (15 to 39 U/mg
protein), CAT (5 to 15 µg/mg protein), GSH (6 to 8 µg/mg protein), GST (13 to 25
mM/min/mg protein), total protein (48 to 58 g/L), albumin (29 to 38 g/L), GLO
(19 to 21 g/L).
[134]
Egypt Decoction (1 h) Wistar rats PCM-induced liver injury
↓ AST (342 to 156 U/L), ALT (359 to 80 U/L), ALP (288 to 263 U/L), LDH
(207 to 143 U/L), GGT (11 to 7 U/L), and total bilirubin (0.3 to 0.2 mg/dL). Restored
SOD (13 to 24 U/g) and CAT (5 to 17 U/g).
[135]
Alkaline phosphatase (ALP); Alanine aminotransferase (ALT); aspirin (ASP); aspartate aminotransferase(AST); catalase (CAT); carbon tetrachloride (CCl4); ethanol (EtOH); gamma
glutamyl transferase (GGT); gastric volume (GV); globulin (GLO); glutathione (GSH); glutathione peroxidase (GPx); glutathione S-transferase (GST); lactate dehydrogenase (LDH); lipid
peroxidation (LPO); mean number lesions (MNL); paracetamol (PCM); pyloric ligation (PL), Serum glutamic oxaloacetic transaminase (SGOT); Serum glutamic pyruvic transaminase
(SGPT), superoxide dismutase (SOD); thioacetamide (TAA); ulcer index (ui); ↑ increases the affect; ↓ decreases the effect.
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2.2.7. Diseases of the Skin and Subcutaneous Tissue
Guava leaves have been suggested as a therapeutic agent to control pruritus in atopic dermatitis.
The improvement of the skin lesions was due to a reduction in serum immunoglobulin E level and in
the eczematous symptoms [136]. Moreover, the epithelium was repaired with connective tissue and
absence or moderate presence of inflammatory cells by the leaves. As a result, the leaves exhibited
wound healing properties [137]. Furthermore, guava leaf extract was tested on rat skin, and exhibited
inhibitory activity towards an active cutaneous anaphylaxis reaction [138].
2.2.8. Other Activities Related to Several Diseases
Triterpenoids from guava leaves were suggested as a potential therapeutic approach for treating
diabetic peripheral neuropathy, as they enhanced physical functions and offered neuronal protection
towards the suppression of the expression of pro-inflammatory cytokines [139]. In addition, the
leaves can act as radio modulators for cancer patients because by preventing DNA damage and
apoptosis. [140], as well as protective agents by restoring the normal values of sperm viability, sperm
count, sperm motility, and sperm-head abnormality caused by caffeine-induced spermatotoxicity [141].
Moreover, the consumption of guava leaf tea was evaluated, in vivo, in the inhibition of
cytochrome P450 (CYP) 3A-mediated drug metabolism by the interaction between guava tea and
several drugs [11,142]. Matsuda et al. [11] investigated the consequence of the ingestion of guava tea
for two weeks in rats, and the effect with an anxiolytic drug. The short-term consumption of the tea
had little effect on the assays performed. This weak influence was due to the absence of interaction
between the tea and midazolam in the metabolism studied. In addition, two in vivo studies were
made in rats, to evaluate the interaction of guava leaf tea with an anti-coagulant drug (warfarin) [142].
Kaneko et al. [141] suggested that because the tea contained compounds that block the affinity between
the enzyme and phenolic compounds of the tea, long-term administration showed a low probability of
causing drug-metabolizing enzymes. Moreover, short-term administration revealed that the tea did
not interfere with coagulation, meaning that the tea consumption did not alter the pharmacological
effect and displayed no side effects.
2.3. Clinical Trials
To test the effect of guava leaf extract, several randomized clinical trials have been conducted
during the last two decades, although only two studies are available in the last decade. One of the
studies consisted of evaluating the effect of guava leaf extract pills on primary dysmenorrhea disorder.
For this, 197 women were divided into four groups, and each received a different dosage: 3 and 6 mg
extract/day, 300 mg placebo/day and 1200 mg ibuprofen/day. The administration took place over
five days during three consecutive cycles. The results demonstrated that 6 mg extract/day alleviated
menstrual pain and could replace the use of medicaments like ibuprofen. In fact, guava leaves could
be used as a broad-spectrum phyto-drug and not only as an anti-spasmodic agent [143]. Furthermore,
Deguchi and Miyazaki [58] reviewed several works regarding the effect of the intake of a commercial
guava leaf tea (Bansoureicha®, Yakult Honsha, Tokyo, Japan) on different pathologies of diabetes
mellitus illness such as the influence on postprandial blood glucose, on insulin resistance and on
hypertriglyceridemia and hypercholesterolemia. The authors concluded that the ingestion of guava leaf
tea can ameliorate the symptoms of diabetes mellitus and that it could be used as an alimentotherapy.
3. Other Applications
Further applications found with guava leaves are listed below: firstly, to prepare gelatin beads
with marine-fish gelatin for various applications such as medicine, and the food and pharmaceutical
industries [144]. Secondly, Giri et al. [145] suggested guava leaves as supplementary feed for the
fish species Labeo rohita, due to the immune-stimulatory effect. The same conclusion was reached
by Fawole et al. [146] in L. rohita. Thirdly, Gobi et al. [147] reported that guava leaf powder, mixed
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with a commercial diet, strengthened the immunological response of Oreochromis mossambicus, and
recommended the leaves as feed complement in aquaculture.
4. Conclusions
Traditional claims generally require experimental research to establish their effectiveness. In this
regard, ethnomedicine applications of Psidium guajava L. leaves have been verified by several researches
over the last decade against many disorders, demonstrating its potential in the treatment of the most
common worldwide diseases. In addition, the effects of the leaves have been related to individual
compounds such as quercetin, catechin, vescalagin, gallic acid, peltatoside, hyperoside, isoquercitrin,
and guaijaverin.
Future prospects should be aimed at investigating the biodiversity of guava and/or the
purification of the different compounds present in guava leaves in order to obtain functional ingredients
for further uses as alternative agents in natural therapeutic approaches.
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